Paraoxonase 1 (PON1) Polymorphisms, Haplotypes and Activity in Predicting CAD Risk in North-West Indian Punjabis
Open Access
- 24 May 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (5), e17805
- https://doi.org/10.1371/journal.pone.0017805
Abstract
Human serum paraoxonase-1 (PON1) prevents oxidation of low density lipoprotein cholesterol (LDL-C) and hydrolyzes the oxidized form, therefore preventing the development of atherosclerosis. The polymorphisms of PON1 gene are known to affect the PON1 activity and thereby coronary artery disease (CAD) risk. As studies are lacking in North-West Indian Punjabi's, a distinct ethnic group with high incidence of CAD, we determined PON1 activity, genotypes and haplotypes in this population and correlated them with the risk of CAD. 350 angiographically proven (≥70% stenosis) CAD patients and 300 healthy controls were investigated. PON1 activity was determined towards paraoxon (Paraoxonase; PONase) and phenylacetate (Arylesterase; AREase) substrates. In addition, genotyping was carried out by using multiplex PCR, allele specific oligonucleotide –PCR and PCR-RFLP methods and haplotyping was determined by PHASE software. The serum PONase and AREase activities were significantly lower in CAD patients as compared to the controls. All studied polymorphisms except L55M had significant effect on PONase activity. However AREase activity was not affected by them. In a logistic regression model, after adjustment for the conventional risk factors for CAD, QR (OR: 2.73 (1.57–4.72)) and RR (OR, 16.24 (6.41–41.14)) genotypes of Q192R polymorphism and GG (OR: 2.07 (1.02–4.21)) genotype of −162A/G polymorphism had significantly higher CAD risk. Haplotypes L-T-G-Q-C (OR: 3.25 (1.72–6.16)) and L-T-G-R-G (OR: 2.82 (1.01–7.80)) were also significantly associated with CAD. In conclusion this study shows that CAD patients had lower PONase and AREase activities as compared to the controls. The coding Q192R polymorphism, promoter −162A/G polymorphism and L-T-G-Q-C and L-T-G-R-G haplotypes are all independently associated with CAD.Keywords
This publication has 61 references indexed in Scilit:
- Paraoxonase 1 Status as a Risk Factor for Disease or ExposureAdvances in experimental medicine and biology, 2009
- Determination of Paraoxonase 1 Status Without the Use of Toxic Organophosphate SubstratesCirculation: Cardiovascular Genetics, 2008
- Prospective Study of Blood and Tibia Lead in Women Undergoing Surgical MenopauseEnvironmental Health Perspectives, 2004
- The 'evolvability' of promiscuous protein functionsNature Genetics, 2004
- Paraoxonase Activity, But Not Haplotype Utilizing the Linkage Disequilibrium Structure, Predicts Vascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Paraoxonase activity in two healthy populations with differing rates of coronary heart diseaseEuropean Journal of Clinical Investigation, 2000
- Paraoxonase PON1 Polymorphism Leu-Met54 Is Associated With Carotid AtherosclerosisStroke, 1998
- Paraoxonase gene polymorphism in Japanese subjects with coronary heart diseaseInternational Journal of Cardiology, 1996
- Paraoxonase Genotypes, Lipoprotein Lipase Activity, and HDLArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- A Polymorphism of the Paraoxonase Gene Associated With Variation in Plasma Lipoproteins in a Genetic IsolateArteriosclerosis, Thrombosis, and Vascular Biology, 1995